Company news

Masimo Corporation news in 2026

Masimo Corporation's news releases, calls and decks from 2026, newest first.

View company

Masimo's smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes

October 17, 2026

Masimo Wins Two OCTANE High Tech Awards - Company Recognized for 'Deal of the Year' and 'Best Technology Leadership Team'

September 30, 2026

Masimo Receives FDA 510(k) Clearance for Root® with LiDCO® and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery (DO₂)

August 25, 2026

Masimo Receives CE Mark for AI-Powered smartSedLine™ Brain Function Monitor to Advance Anesthetic Management

August 18, 2026

Masimo Appoints Tim Benner as President

August 3, 2026

Masimo Receives FDA 510(k) Clearance for the Pediatric Patient State Index, the First-and-Only Sedation Score Specifically Designed for the Unique Physiology of the Pediatric Brain

July 27, 2026

Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner

June 22, 2026

Quarterly Report for Quarter Ending April 4, 2026 (Form 10-Q)

May 5, 2026

Masimo Shareholders Approve Acquisition by Danaher

May 4, 2026

Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study

April 27, 2026

Masimo to be Acquired by Danaher for $180.00 Per Share

February 17, 2026

Masimo to Report Fourth Quarter and Full Year 2025 Financial Results after Market Close on Thursday, February 26

February 12, 2026

Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the Board

January 21, 2026

Masimo Announces Select Preliminary 2025 Financial Results

January 11, 2026

Masimo to Present in the J.P. Morgan 2026 Healthcare Conference

January 6, 2026

Decks in 2026